Less common but potentially serious risks may include pancreatitis (inflammation of the pancreas), gallbladder problems, kidney damage, allergic reactions, and thyroid tumors
Advice for Healthcare Professionals The MHRA has advised that healthcare professionals remain vigilant for symptoms of acute pancreatitis, which may be challenging to recognise in early stages, and use GLP-1/GIP receptor agonists and GLP-1RAs with caution in patients with a history of pancreatitis
If your thyroid is the primary driver, treating that first will be more effective than layering a GLP-1 on top of an undiagnosed condition
Specialty high-drain cells can have slightly higher ratings (up to 4.25V), but handling and appropriate chargers are needed for these
pp 20528
Frequently Asked Questions (FAQs) How often should ipamorelin be administered for best results